Anavex Life Sciences Corp (AVXL)

[Steady_T]

As far as I can find there are no fees for meetings with the FDA. There are fees for filing an NDA which as far as we know Anavex has not yet done.
Even so the NDA filing fee is waved for an NDA for an orphan drug. 2-73 has orphan drug designation for Rett so no NDA filing fee.

FY 2023 and FY 2024 User Fee Rates 
 Fee Category	Fee Rates for FY 2023	Fee Rates for FY 2024 
 Application	 	  
      Requiring clinical data	$3,242,026	$4,048,695 
      Not requiring clinical data	$1,621,013	$2,024,348 
 Program	$393,933	$416,734

Designated Orphan Drug or Indication:

An application for a prescription drug product that has been designated as a drug for a rare disease or condition under section 526 of the FD&C Act is not subject to an application fee unless the application includes an indication for other than a rare disease or condition.